innohep 4.500 UI anti-Xa/0 clinical trials

Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment.

This study looks at whether a blood-thinning medicine called tinzaparin can help prevent blood clots in people with advanced bowel cancer who are starting their first treatment. It aims to see how well it works to reduce the risk of different types of blood clots.